NodThera is developing a new class of potent and highly selective NLRP3 inflammasome inhibitors for the treatment of diseases driven by chronic inflammation. We’re building a dynamic team of people across our offices in Cambridge, UK; Seattle, WA; and Boston, MA; all united by our shared ambition, enthusiasm, and creativity.
View Top Employees from NodTheraWebsite | https://nodthera.com |
Revenue | $8.5 million |
Funding | $95 million |
Employees | 28 (28 on RocketReach) |
Founded | 2016 |
Address | 265 Franklin St. Suite 1702, Boston, Massachusetts 02110, US |
Phone | (617) 866-7350 |
Technologies |
JavaScript,
HTML,
PHP
+8 more
(view full list)
|
Industry | Biotechnology Research, Business Services General, Biotechnology, Business Services, Science and Engineering, Life Science |
Competitors | Cocrystal Pharma, Inc., Egenix INC, GlycoMimetics, Second Genome Inc., Visterra Inc. |
SIC | SIC Code 87 Companies, SIC Code 873 Companies |
NAICS | NAICS Code 541 Companies, NAICS Code 54 Companies, NAICS Code 541714 Companies, NAICS Code 5417 Companies, NAICS Code 54171 Companies |
Looking for a particular NodThera employee's phone or email?
The NodThera annual revenue was $8.5 million in 2024.
Valerie Reader is the Vice President of Scientific Operations of NodThera.
28 people are employed at NodThera.
NodThera is based in Boston, Massachusetts.
The NAICS codes for NodThera are [541, 54, 541714, 5417, 54171].
The SIC codes for NodThera are [87, 873].